Prenatal diagnosis of steroid 21-hydroxylase deficiency by allele-specific amplification.
OBJECTIVE
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency (21-OHD) is the most common cause of ambiguous genitalia in females at birth. Here, we report the first prenatal diagnosis of 21-OHD by DNA analysis in Hungary.


METHODS
Allele-specific amplification (ASA) of the DNA obtained by chorionic villus sampling was performed.


RESULTS
The fetus had a homozygous nonsense mutation (Gln318Stop), suggesting a salt-wasting phenotype. Dexamethasone treatment of the mother was started on the 8th gestational week and, as the fetus was an affected female, it was continued until term. The newborn had normal external genitalia at birth, and severe salt-wasting crisis and postnatal virilization was prevented by mineralo- and glucocorticoid replacement therapy.


CONCLUSIONS
21-OHD was genotyped by ASA, and virilization of the fetus was prevented by antenatal dexamethasone therapy.
Theodoropoulou
M
M
Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Budapest, Hungary.
Barta
C
C
Szoke
M
M
Guttman
A
A
Staub
M
M
Niederland
T
T
Sólyom
J
J
Fekete
G
G
Sasvari-Szekely
M
M
D000312:Adrenal Hyperplasia, Congenital / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics*; D000483:Alleles; D004252:DNA Mutational Analysis; D003907:Dexamethasone / Q000008:administration & dosage; D005260:Female; D005838:Genotype; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D016133:Polymerase Chain Reaction; D011247:Pregnancy; D011296:Prenatal Diagnosis; D013255:Steroid 21-Hydroxylase / Q000235:genetics*
D005938:Glucocorticoids; D003907:Dexamethasone; D013255:Steroid 21-Hydroxylase